PUBLIC-HEALTH-SERVICE

FDA Delays Effective Date for Statutory Evaluations

The Food and Drug Administration (FDA) has issued a correction to delay the effective date for certain statutory evaluations. This administrative delay affects rules published under the Department of Health and Human Services and its various agencies.

Approval of Respiratory Protective Devices

The Public Health Service, through the Department of Health and Human Services, has issued a final rule regarding the approval of respiratory protective devices. This rule is published in the Federal Register and pertains to specific regulations within 42 CFR 84.

FDA Proposal to Withdraw or Repeal Statutory Evaluations

The Food and Drug Administration, along with other HHS agencies, has proposed to withdraw or repeal certain statutory evaluations. This action is part of an effort to secure updated and necessary evaluations. The proposal is open for public comment.

Administrative Delay of Statutory Evaluations Effective Date

The Department of Health and Human Services, through multiple agencies including FDA, CMS, and ACF, has issued a final rule to administratively delay the effective date of certain statutory evaluations. This rule impacts the implementation timeline for these evaluations, providing additional administrative time.

Withdrawing Rule on Securing Updated Statutory Evaluations

The Department of Health and Human Services, through multiple agencies including FDA and CMS, has withdrawn a final rule concerning the timely securing of updated statutory evaluations. This withdrawal action removes the previously established requirements related to these evaluations.